Follow the 카이바이오텍 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 카이바이오텍 has logged 13 reports. The latest transaction was filed on 20 September 2024 (Purchase). Among the most active insiders: 케이비인베스트먼트. The full history is free.
13
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
6 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.